ProMIS Neurosciences (PMN) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
9 Apr, 2026Executive summary
Annual meeting scheduled for May 20, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by May 19, 2026.
Voting matters and shareholder proposals
Election of seven directors to serve until the next annual meeting or until successors are elected.
Ratification of Baker Tilly US, LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Approval of an amendment to the 2025 Stock Option and Incentive Plan.
Board recommends voting in favor of all proposals.
Board of directors and corporate governance
Seven nominees listed for director positions, including Eugene Williams, Neil Cashman, Joshua Mandel-Brehm, Maggie Shafmaster, Neil K. Warma, William Wyman, and Slanix Alex.
Latest events from ProMIS Neurosciences
- Interim PRECISE-AD trial data showed strong safety, biomarker progress, and cash runway through 2027.PMN
Q2 2026 - Blinded interim data show strong safety and early biomarker improvement in Alzheimer's patients.PMN
Study result - Interim phase I-B Alzheimer's data expected early Q3, with strong funding and pipeline momentum.PMN
2026 Bloom Burton & Co. Healthcare Investor Conference - Interim safety and biomarker data for a selective Alzheimer's antibody are expected in early Q3.PMN
Jefferies Global Healthcare Conference 2026 - Board elections, clinical trial progress, and major financing mark a pivotal year.PMN
AGM 2026 - Q1 2026 net loss $8.2M, $175M PIPE closed, Alzheimer's trial milestones on track.PMN
Q1 2026 - PMN310 targets toxic amyloid-beta in Alzheimer's, with pivotal data expected in 2026.PMN
Investor presentation - Phase 1b Alzheimer's trial fully enrolled; data and platform validation expected this year.PMN
Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Shareholders will vote on board elections, auditor ratification, and expanding the stock option plan.PMN
Proxy filing